These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12970256)

  • 1. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a Swine endothelial dysfunction model.
    Ruel M; Wu GF; Khan TA; Voisine P; Bianchi C; Li J; Li J; Laham RJ; Sellke FW
    Circulation; 2003 Sep; 108 Suppl 1():II335-40. PubMed ID: 12970256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.
    Voisine P; Li J; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Rosinberg A; Malik T; Nakai Y; Sellke FW
    Circulation; 2005 Aug; 112(9 Suppl):I202-7. PubMed ID: 16159817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-arginine on the endogenous angiogenic response in a model of hypercholesterolemia.
    Nakai Y; Voisine P; Bianchi C; Xu SH; Feng J; Malik T; Rosinberg A; Sellke FW
    Surgery; 2005 Aug; 138(2):291-8. PubMed ID: 16153439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
    Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
    Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor.
    Voisine P; Bianchi C; Ruel M; Malik T; Rosinberg A; Feng J; Khan TA; Xu SH; Sandmeyer J; Laham RJ; Sellke FW
    Surgery; 2004 Aug; 136(2):407-15. PubMed ID: 15300208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine.
    Boodhwani M; Mieno S; Voisine P; Feng J; Sodha N; Li J; Sellke FW
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1299-306. PubMed ID: 17140946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of l-arginine in a porcine model of endothelial dysfunction.
    Voisine P; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Li J; Malik T; Rosinberg A; Sellke FW
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1414-20. PubMed ID: 15942586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress.
    Boodhwani M; Nakai Y; Mieno S; Voisine P; Bianchi C; Araujo EG; Feng J; Michael K; Li J; Sellke FW
    Ann Thorac Surg; 2006 Feb; 81(2):634-41. PubMed ID: 16427865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial ischemia.
    Xu X; Li J; Simons M; Li J; Laham RJ; Sellke FW
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):735-42. PubMed ID: 11279416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia.
    Laham RJ; Rezaee M; Post M; Novicki D; Sellke FW; Pearlman JD; Simons M; Hung D
    J Pharmacol Exp Ther; 2000 Feb; 292(2):795-802. PubMed ID: 10640320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium.
    Donnini S; Solito R; Giachetti A; Granger HJ; Ziche M; Morbidelli L
    J Pharmacol Exp Ther; 2006 Nov; 319(2):515-22. PubMed ID: 16868034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise training enhances vasodilation responses to vascular endothelial growth factor in porcine coronary arterioles exposed to chronic coronary occlusion.
    Fogarty JA; Muller-Delp JM; Delp MD; Mattox ML; Laughlin MH; Parker JL
    Circulation; 2004 Feb; 109(5):664-70. PubMed ID: 14769688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of myocardial perfusion and vascular reactivity by pericardial basic fibroblast growth factor: insight into ischemia-induced reduction in endothelium-dependent vasodilatation.
    Laham RJ; Simons M; Tofukuji M; Hung D; Sellke FW
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1022-8. PubMed ID: 9832695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ischemic preconditioning on myocardial perfusion, function, and microvascular regulation.
    Tofukuji M; Metais C; Li J; Hariawala MD; Franklin A; Vassileva C; Li J; Simons M; Sellke FW
    Circulation; 1998 Nov; 98(19 Suppl):II197-204; discussion II204-5. PubMed ID: 9852903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo.
    Nishida T; Shimokawa H; Oi K; Tatewaki H; Uwatoku T; Abe K; Matsumoto Y; Kajihara N; Eto M; Matsuda T; Yasui H; Takeshita A; Sunagawa K
    Circulation; 2004 Nov; 110(19):3055-61. PubMed ID: 15520304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia.
    Sabe AA; Potz BA; Elmadhun NY; Liu Y; Feng J; Abid MR; Abbott JD; Senger DR; Sellke FW
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):245-52. PubMed ID: 26478238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.
    Hughes GC; Biswas SS; Yin B; Coleman RE; DeGrado TR; Landolfo CK; Lowe JE; Annex BH; Landolfo KP
    Ann Thorac Surg; 2004 Mar; 77(3):812-8. PubMed ID: 14992878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction.
    Boodhwani M; Voisine P; Ruel M; Sodha NR; Feng J; Xu SH; Bianchi C; Sellke FW
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):645-50; discussion 251-2. PubMed ID: 18201892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit myocardium.
    Bougioukas I; Didilis V; Ypsilantis P; Giatromanolaki A; Sivridis E; Lialiaris T; Mikroulis D; Simopoulos C; Bougioukas G
    Cardiovasc Pathol; 2007; 16(2):63-8. PubMed ID: 17317537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
    Osto E; Matter CM; Kouroedov A; Malinski T; Bachschmid M; Camici GG; Kilic U; Stallmach T; Boren J; Iliceto S; Lüscher TF; Cosentino F
    Circulation; 2008 Nov; 118(20):2073-80. PubMed ID: 18955669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.